Presentation Date News Today

Onera Health exhibits and presents the latest data in poster abstracts at SLEEP 2024, the Associated Professional Sleep Societies, LLC (APSS) annual meeting. Onera Health, a leader in transforming

-- Presentations include new data from OCEAN, ROSE, and ROSE2 Phase 2 clinical trials, demonstrating obicetrapib’s impact on key lipid and lipoprotein biomarkers --

– New data include 24-month results from the largest and longest prospective natural history study of children and adolescents with Dravet syndrome, which showed a lack of improvement despite...

15.11.2023 - EMERYVILLE, Calif., Nov. 15, 2023 (GLOBE NEWSWIRE) - 4D Molecular Therapeutics, Inc. (Nasdaq: FDMT, 4DMT, or the Company), a genetic medicines company with three novel, highly targeted next generation AAV vectors currently in human clinical ...

BOTHELL, Wash., Sept. 19, 2023 -- Athira Pharma, Inc. , a late clinical-stage biopharmaceutical company focused on developing small molecules to restore neuronal health and slow neurodegeneration,...

Long-Term Follow Up Data from Phase 1 ALPHA/ALPHA2 Trials Demonstrates Potential of Allogeneic CD19 CAR T to Generate Durable Complete Responses Similar to...

FinancialContent fully hosted finance channel

Onera Health has announced the formation of a Medical Advisory Board ahead of SLEEP 2023, the Associated Professional Sleep Societies, LLC (APSS) annual meeting, where the company exhibits and presents

Onera Health, developer of a patch-based home sleep test, established a medical advisory board to support company growth.

Cortisol levels in late pregnancy can predict the sleep of infants, according to a new study to be presented at the SLEEP 2023 annual meeting.